Skip to content
Comparison

Ipamorelin + CJC-1295 vs GHRP-6 + CJC-1295

Ipamorelin + CJC-1295 and GHRP-6 + CJC-1295 are commonly compared for two popular GH stack architectures. Ipamorelin + CJC-1295 is usually favored for cleaner profile with lower appetite/cortisol burden, while GHRP-6 + CJC-1295 is often preferred for higher appetite and raw GH-drive profile. This head-to-head analysis focuses on mechanism, trial outcomes, dosing context, evidence quality, regulatory status, and practical decision points for safer YMYL decision-making.

4.3(112 ratings)

Quick Answer

For two popular GH stack architectures, the better choice depends on your primary endpoint. Ipamorelin + CJC-1295 is stronger when the priority is longer tolerable GH stack cycles. GHRP-6 + CJC-1295 is stronger when the priority is mass-gain protocols accepting higher side-effect load. Use evidence grade, dose intensity, access constraints, and tolerability profile to match therapy to the patient profile rather than choosing by hype alone.

Head-to-Head Comparison

CriteriaIpamorelin + CJC-1295GHRP-6 + CJC-1295
Primary mechanismGHRP + GHRH synergy for amplified GH pulse generationHigh-output GHRP/GHRH stack emphasizing GH release intensity
Strongest clinical signalStronger GH pulse architecture than either agent aloneStrong GH signal with appetite-enhancing profile
Typical dosing contextOften 100-200 mcg of each peptide per dose, 1-3x dailyCommonly paired microgram injections 1-3x daily
AdministrationSubcutaneous injectionSubcutaneous injection
Evidence quality gradeModerate mechanistic support and extensive protocol useModerate class evidence and historical protocol use
Regulatory statusNot FDA-approved combinationResearch-use combination
Side-effect burdenDepends on dose and frequency; monitor IGF-1/metabolic markersMore appetite/cortisol burden than ipamorelin-based stacks
Cost/access contextHigher than single-agent protocolsModerate protocol cost
Best candidate profileUsers aiming for pulse-amplified GH optimizationMass-gain contexts where appetite increase is acceptable
Main limitationProtocol complexity and adherence burdenSide effects often limit broad clinical usability
Best use case in this comparisonlonger tolerable GH stack cyclesmass-gain protocols accepting higher side-effect load

When to Choose Each

Choose Ipamorelin + CJC-1295

Best for longer tolerable GH stack cycles.

Choose GHRP-6 + CJC-1295

Best for mass-gain protocols accepting higher side-effect load.

Verdict

If the main goal is longer tolerable GH stack cycles, Ipamorelin + CJC-1295 is usually the better first-line choice. If the main goal is mass-gain protocols accepting higher side-effect load, GHRP-6 + CJC-1295 is typically the better fit. Reassess outcomes at 8-16 weeks with objective metrics, then adjust only when response, safety, or adherence data justify it. In high-risk populations, physician-guided personalization matters more than any generic ranking.

References

  1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults (2006) — PubMed
  2. Ipamorelin, the first selective growth hormone secretagogue (1998) — PubMed
  3. Ghrelin is a growth-hormone-releasing acylated peptide from stomach (1999) — PubMed
  4. A synthetic GH secretagogue (MK-677) and a GHRH analog (CJC-1295) act synergistically to promote GH release in humans (2008) — PubMed

Compare Telehealth Providers

Find the right provider for your peptide therapy needs

Hims & Hers

Most Popular
4.3

Starting at $199/mo

Hims & Hers is a leading telehealth platform offering physician-supervised GLP-1 weight loss programs including compounded semaglutide and tirzepatide. Board-certified providers, async or video consults, and medication shipped to your door.

✓Large, established platform with strong physician network
✓Compounded semaglutide available where branded shortages exist
✓Easy async consult — no video call required
✗Does not offer a wide range of peptides beyond GLP-1s
✗Pricing is on the higher end for GLP-1 programs

Henry Meds

Most Peptides
4.2

Starting at $249/mo

Henry Meds is a telehealth provider specializing in hormone optimization and peptide therapy. Beyond GLP-1 weight loss, Henry Meds offers testosterone replacement therapy, growth hormone peptides, and other advanced hormonal protocols managed by licensed physicians.

✓Broadest peptide therapy menu of any major telehealth provider
✓Growth hormone peptides (sermorelin, ipamorelin, CJC-1295) available
✓Repair peptides including BPC-157 and TB-500
✗Higher starting price due to comprehensive programs
✗More complex onboarding including lab work requirements

Ro Body

Best Value
4.1

Starting at $149/mo

Ro Body is a telehealth weight management program powered by GLP-1 medications. Ro connects patients with licensed providers who prescribe compounded semaglutide or branded GLP-1 therapies depending on eligibility, paired with behavioral coaching.

✓Competitive pricing starting at $149/mo
✓Dedicated health coach included in program
✓Strong clinical protocols with lab-work integration
✗Narrower peptide offering — GLP-1s only
✗Video consult required for initial visit

Calibrate

4.0

Starting at $199/mo

Calibrate is a metabolic health company offering a one-year GLP-1 program built around four pillars: food, sleep, exercise, and emotional health. Calibrate works with insurance to cover medication costs and provides extensive behavioral coaching alongside prescriptions.

✓Insurance navigation support for medication coverage
✓Evidence-based one-year program with structured milestones
✓Four-pillar lifestyle coaching (food, sleep, exercise, emotional health)
✗Annual program commitment required
✗Primarily focused on GLP-1s — no broader peptide therapy

Found

3.9

Starting at $129/mo

Found is a weight management telehealth platform that combines GLP-1 medications with behavioral coaching and a supportive community. Found emphasizes a whole-person approach, pairing pharmacological treatment with lifestyle intervention for sustainable results.

✓One of the more affordable monthly program fees
✓Strong community and peer support features
✓Certified health coaches with regular check-ins
✗Medication billed separately from program fee — total cost can be higher
✗Limited peptide variety beyond standard GLP-1s

Sponsored · We may earn a commission. Learn more · Updated February 2026

Henry MedsMost Peptides

Henry Meds is a telehealth provider specializing in hormone optimization and peptide therapy. Beyond GLP-1 weight loss, Henry Meds offers testosterone replacement therapy, growth hormone peptides, and other advanced hormonal protocols managed by licensed physicians.

From $249/moLearn More →

Sponsored · Affiliate Disclosure

Frequently Asked Questions

Which has stronger evidence for two popular GH stack architectures — Ipamorelin + CJC-1295 or GHRP-6 + CJC-1295?
Ipamorelin + CJC-1295 is graded as moderate mechanistic support and extensive protocol use evidence in this context, while GHRP-6 + CJC-1295 is graded as moderate class evidence and historical protocol use. In practice, strength depends on whether you prioritize longer tolerable GH stack cycles or mass-gain protocols accepting higher side-effect load. Favor the option with endpoint data closest to your primary goal, and avoid extrapolating beyond studied populations.
Can Ipamorelin + CJC-1295 and GHRP-6 + CJC-1295 be combined or sequenced?
Sometimes, but only with clinician oversight. A common framework is to start with one agent, track objective response for 8-16 weeks, then switch or sequence if outcomes plateau or tolerability is poor. Combination protocols may increase both cost and adverse-effect complexity, so they should be justified by clear endpoint-based rationale.
What should be monitored before and during treatment?
Baseline assessment should include diagnosis confirmation, comorbidity risk, and contraindications. During therapy, monitor target outcomes (symptoms, body composition, labs), adverse effects, and adherence burden. For endocrine/metabolic strategies, periodic glucose, lipids, organ function, and indication-specific labs help keep risk proportional to expected benefit.

Explore next